Qiao Lili, Liang Ning, Zhang Jiandong, Xie Jian, Liu Fengjun, Xu Deguo, Yu Xinshuang, Tian Yuan
Department of Oncology, Shandong University School of Medicine, Jinan, Shandong Pro, China.
J Cell Mol Med. 2015 Feb;19(2):315-26. doi: 10.1111/jcmm.12496. Epub 2015 Jan 19.
Vasculogenic mimicry (VM) is a brand-new tumour vascular paradigm independent of angiogenesis that describes the specific capacity of aggressive cancer cells to form vessel-like networks that provide adequate blood supply for tumour growth. A variety of molecule mechanisms and signal pathways participate in VM induction. Additionally, cancer stem cell and epithelial-mesenchymal transitions are also shown to be implicated in VM formation. As a unique perfusion way, VM is associated with tumour invasion, metastasis and poor cancer patient prognosis. Due to VM's important effects on tumour progression, more VM-related strategies are being utilized for anticancer treatment. Here, with regard to the above aspects, we make a review of advanced research on VM in cancer.
血管生成拟态(VM)是一种全新的、独立于血管生成的肿瘤血管模式,它描述了侵袭性癌细胞形成类似血管网络的特定能力,这些网络为肿瘤生长提供充足的血液供应。多种分子机制和信号通路参与了VM的诱导。此外,癌症干细胞和上皮-间质转化也被证明与VM的形成有关。作为一种独特的灌注方式,VM与肿瘤侵袭、转移及癌症患者的不良预后相关。由于VM对肿瘤进展具有重要影响,越来越多与VM相关的策略正被用于抗癌治疗。在此,针对上述方面,我们对癌症中VM的前沿研究进行综述。